ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 110 filers reported holding ERASCA INC in Q3 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,743,347 | -41.5% | 3,930,633 | -18.1% | 0.36% | -29.0% |
| Q2 2023 | $13,240,990 | -8.3% | 4,797,460 | 0.0% | 0.51% | -19.4% |
| Q1 2023 | $14,440,355 | -30.2% | 4,797,460 | 0.0% | 0.64% | -13.8% |
| Q4 2022 | $20,677,053 | -63.5% | 4,797,460 | -34.0% | 0.74% | -63.9% |
| Q3 2022 | $56,667,000 | +73.0% | 7,264,981 | +23.5% | 2.05% | +64.0% |
| Q2 2022 | $32,759,000 | -20.5% | 5,881,382 | +22.7% | 1.25% | -18.9% |
| Q1 2022 | $41,206,000 | -46.5% | 4,791,406 | -7.7% | 1.54% | -41.2% |
| Q4 2021 | $76,954,000 | -21.6% | 5,191,405 | 0.0% | 2.62% | -9.2% |
| Q3 2021 | $98,172,000 | – | 5,191,405 | – | 2.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |